No fees unless we win.
Get a free consultation
According to the Los Angeles Times, a group of researchers from the City of Hope in Duarte, California have developed a way to identify drugs and chemicals, which can disrupt hormones in humans and influence the development of diseases such as breast cancer.
The Times reported that in a trial screening of 446 drugs, the antidepressant Paxil (paroxetine) was found to have a weak estrogenic effect that could promote the development and growth of breast tumors in women.
The paper said the discovery was important because as many as a quarter of women treated for breast cancer suffer from depression, which is commonly treated with SSRIs (selective serotonin reuptake inhibitors) like Paxil.
“The discovery that Paxil behaves as an endocrine-disrupting chemical may shed light on growing suspicions about the medication in women who have had breast cancer,” the Times reported. “A 2010 study found that breast cancer patients in Canada who were taking Paxil were more likely than those taking other antidepressants to die of breast cancer when there was a substantial overlap in their use of that antidepressant and of tamoxifen to prevent breast cancer recurrence.”
The researchers discovered that taking Paxil might block the production of a liver enzyme needed to metabolize tamoxifen.
If you are taking Paxil and have breast cancer, you should consult your physician. You can also speak to our experienced defective drug attorneys. Paxil, and other SSRIs including Prozac, Zoloft, Lexapro, Luvox and Celexa, have been linked to other health issues, as well as persistent pulmonary hypertension (PPHN) in newborns.
For more information about antidepressants and injuries, talk with our SSRI lawyers by calling (888) 841-9623
for a free initial review of your case.
Michelle is a founding partner of Zoll & Kranz, located in Toledo, Ohio. Michelle has been a plaintiff’s lawyer for the entirety of her practice – over 32 years. She devotes the majority of her time to complex consolidated litigation and class action including advocating for people injured by medical devices, prescription medications, or corporate negligence.
This article has been written and reviewed for legal accuracy and clarity by the team of writers and attorneys at Zoll & Kranz, LLC and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced Ohio injury lawyer, Michelle L. Kranz, you can do so here.
Zoll & Kranz, LLC does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us. This article should not be taken as advice from an attorney.
A serious injury can have life-altering results.
Don’t settle for less than you deserve, speak with an award-winning personal injury lawyer today.
FDA Warns Pfizer’s Drug Tygacil Raises Risk of Death
FDA Announces da Vinci Surgical System Robot Recall
FDA Issues Warning Over Phillips Heart Defibrillators
FDA Issues Warning About Medtronic Guidewire Recall
Unsterile Medical Device Recall: Zoll & Kranz, LLC is investigating the Seprafilm Class II Recall
For over 37 years, Zoll & Kranz has been fighting for clients who have been the victims of the wrongful death of a loved one.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!
A serious injury can have life-altering results.
Don’t settle for less than you deserve, speak with an award-winning personal injury lawyer today.
